Deutsche Bank’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$501K Buy
7,451
+813
+12% +$60.3K ﹤0.01% 2577
2025
Q4
$524K Buy
+6,638
New +$452K ﹤0.01% 2538
2025
Q3
Sell
-4,684
Closed -$66.8K 3662
2025
Q2
$66.8K Sell
4,684
-2,759
-37% -$35.7K ﹤0.01% 3372
2025
Q1
$104K Sell
7,443
-12,166
-62% -$165K ﹤0.01% 3178
2024
Q4
$302K Buy
19,609
+19,487
+15,973% +$297K ﹤0.01% 2906
2024
Q3
$1.91K Hold
122
﹤0.01% 3574
2024
Q2
$1.73K Buy
+122
New +$1.91K ﹤0.01% 3527

Other funds holding INBX

Deutsche Bank's INBX Position: Q1 2026 in Review

Deutsche Bank increased its Inhibrx (INBX) stake by 12% in Q1 2026, buying an estimated $60.3K and bringing the position to 7,451 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Deutsche Bank first reported a position in INBX in Q2 2024 and has held it in 7 quarters since. The position peaked at $524K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Deutsche Bank held 7,451 shares of Inhibrx worth $501K as of Q1 2026.
  • Deutsche Bank bought 813 Inhibrx shares in Q1 2026, an estimated $60.3K.
  • Inhibrx made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2577 holding.
  • Deutsche Bank first reported a position in Inhibrx in Q2 2024 and has held it in 7 quarters since.
  • Deutsche Bank's Inhibrx position peaked at $524K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.